TITLE

Hip fracture risk in relation to vitamin D supplementation and serum 25-hydroxyvitamin D levels: a systematic review and meta-analysis of randomised controlled trials and observational studies

AUTHOR(S)
Lai, Jeffrey K. C.; Lucas, Robyn M.; Clements, Mark S.; Roddam, Andrew W.; Banks, Emily
PUB. DATE
January 2010
SOURCE
BMC Public Health;2010, Vol. 10, p331
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Vitamin D supplementation for fracture prevention is widespread despite conflicting interpretation of relevant randomised controlled trial (RCT) evidence. This study summarises quantitatively the current evidence from RCTs and observational studies regarding vitamin D, parathyroid hormone (PTH) and hip fracture risk. Methods: We undertook separate meta-analyses of RCTs examining vitamin D supplementation and hip fracture, and observational studies of serum vitamin D status (25-hydroxyvitamin D (25(OH)D) level), PTH and hip fracture. Results from RCTs were combined using the reported hazard ratios/relative risks (RR). Results from case-control studies were combined using the ratio of 25(OH)D and PTH measurements of hip fracture cases compared with controls. Original published studies of vitamin D, PTH and hip fracture were identified through PubMed and Web of Science databases, searches of reference lists and forward citations of key papers. Results: The seven eligible RCTs identified showed no significant difference in hip fracture risk in those randomised to cholecalciferol or ergocalciferol supplementation versus placebo/control (RR = 1.13[95%CI 0.98-1.29]; 801 cases), with no significant difference between trials of <800 IU/day and ⩾800 IU/day. The 17 identified case-control studies found 33% lower serum 25(OH)D levels in cases compared to controls, based on 1903 cases. This difference was significantly greater in studies with population-based compared to hospital-based controls (?2 1 (heterogeneity) = 51.02, p < 0.001) and significant heterogeneity was present overall (?2 16 (heterogeneity) = 137.9, p < 0.001). Serum PTH levels in hip fracture cases did not differ significantly from controls, based on ten case-control studies with 905 cases (?2 9 (heterogeneity) = 149.68, p < 0.001). Conclusions: Neither higher nor lower dose vitamin D supplementation prevented hip fracture. Randomised and observational data on vitamin D and hip fracture appear to differ. The reason for this is unclear; one possible explanation is uncontrolled confounding in observational studies. Post-fracture PTH levels are unrelated to hip fracture risk.
ACCESSION #
52839529

 

Related Articles

  • Economic evaluation of parathyroid hormone (PTH) in the treatment of osteoporosis in postmenopausal women. Lundkvist, J.; Johnell, O.; Cooper, C.; Sykes, D. // Osteoporosis International;Feb2006, Vol. 17 Issue 2, p201 

    Parathyroid hormone (PTH) is a new treatment for osteoporosis and has been shown to reduce the risks of vertebral and non-vertebral fractures in postmenopausal women in clinical trials. The objective of this study was to estimate the cost-effectiveness of teriparatide in addition to calcium and...

  • To prevent fractures, find the right dose of vitamin D.  // Contemporary OB/GYN;Jul2005, Vol. 50 Issue 7, p16 

    Discusses research being done on the importance of vitamin D supplementation to fracture prevention. Reference to a study by W. C. Willett et al, published in the 2005 issue of the "Journal of the American Medical Association"; Dose of vitamin D which is efficient in preventing fractures;...

  • Recent developments in vitamin D deficiency and muscle weakness among elderly people. Venning, Geoff // BMJ: British Medical Journal (International Edition);3/5/2005, Vol. 330 Issue 7490, p524 

    Presents a review that discusses recent developments in screening and treating vitamin D deficiency among elderly housebound people aimed at reducing the incidence of falls and fractures. Association of vitamin D deficiency with muscle weakness as well as osteomalacia; Need for the...

  • Decreased cutaneous vitamin D-synthesis in heavily melanized individuals: A rare cause for pathologic fractures of the hip. Berger, Christian E.; Marteau, Robert; Pabinger, Christoph; Kröner, Andreas; Ogris, Emil; Engel, Alfred // Wiener Klinische Wochenschrift;2003, Vol. 115 Issue 5/6, p186 

    Painful pathological fractures of the femoral neck and the subtrochanteric region of the femur are reported in two women originating from India. After exclusion of renal or intestinal causes, laboratory data on bone metabolism, scintigraphic and radiographic examinations were characteristic for...

  • Review: Oral vitamin D prevents nonvertebral and hip fractures in a dose-dependent manner in patients greater than or equal to 65 years of age. Denman, Michael; Bischoff-Ferrari, H. A. // ACP Journal Club;8/18/2009, Vol. 151 Issue 2, p6 

    The article reports that oral vitamin D prevents nonvertebral and hip fractures in a dose-dependent manner in patients of 65 years of age. The study said that value of oral vitamin D supplements in preventing nonvertebral fractures in older patients has remained unresolved because of conflicting...

  • Calcium and vitamin D is effective for preventing first fracture.  // BMJ: British Medical Journal (International Edition);7/30/2005, Vol. 331 Issue 7511, preceding p245 

    Focuses on whether supplementation with vitamin D and calcium will prevent a first hip fracture or non vertebral fracture in older people. Description of a study of vitamin D and calcium; Conclusion that supplementation with calcium and vitamin D daily decreases the likelihood that older people...

  • Vitamin (D)aylight. HARRY, PIP // Good Health (Australia Edition);Jul2011, p48 

    The article offers information on vitamin D, the importance of vitamin D, and the problems which are caused by the deficiency of vitamin D. Vitamin D is a hormone that plays an important role in maintaining bone strength. The deficiency of vitamin D in children can lead to rickets, and its...

  • Addressing the Musculoskeletal Components of Fracture Risk with Calcium and Vitamin D: A Review of the Evidence. Boonen, S.; Bischoff-Ferrari, H. A.; Cooper, C.; Lips, P.; Ljunggren, O.; Meunier, P. J.; Reginster, J.-Y. // Calcified Tissue International;May2006, Vol. 78 Issue 5, p257 

    Osteoporotic fractures are an extremely common and serious health problem in the elderly. This article presents the rationale for calcium and vitamin D supplementation in the prevention and treatment of osteoporotic fractures and reviews the literature evidence on the efficacy of this strategy....

  • Calcium, vitamin D reduce fracture risk in people over 50.  // Contemporary OB/GYN;Oct2007, Vol. 52 Issue 10, p28 

    This article focuses on a review of published studies that appeared in the August 25, 2007 issue of "The Lancet," which revealed that calcium supplementation alone or with vitamin D reduces the risk of fracture and the rate of bone loss in middle-aged and elderly individuals. In the 17 trials...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics